focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: HSBC Raises Berkeley And McCarthy & Stone

Mon, 09th Sep 2019 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

HSBC RAISES BERKELEY GROUP TO 'BUY' ('HOLD') - PRICE TARGET 4540 (4130) PENCE

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 4800 (4700) PENCE - 'BUY'

----------

HSBC CUTS TAYLOR WIMPEY PRICE TARGET TO 210 (230) PENCE - 'BUY'

----------

HSBC CUTS PERSIMMON PRICE TARGET TO 2750 (2960) PENCE - 'BUY'

----------

HSBC CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 750 (770) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ST JAMES'S PLACE PRICE TARGET TO 980 (1030) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS LEGAL & GENERAL PRICE TARGET TO 245 (260) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 7800 (7600) PENCE - 'BUY'

----------

BERENBERG CUTS CENTRICA PRICE TARGET TO 80 (140) PENCE - 'HOLD'

----------

BERENBERG RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 8115 (6340) PENCE - 'BUY'

----------

FTSE 250

----------

BERENBERG CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY') - TARGET 572 (475) PENCE

----------

UBS CUTS ASHMORE GROUP PRICE TARGET TO 480 (505) PENCE - 'NEUTRAL'

----------

DAVY CUTS WIZZ AIR TO 'NEUTRAL' ('OUTPERFORM')

----------

RBC CUTS DUNELM GROUP PRICE TARGET TO 850 (900) PENCE - 'UNDERPERFORM'

----------

BARCLAYS CUTS ASHMORE GROUP PRICE TARGET TO 520 (540) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES ULTRA ELECTRONICS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 2000 (1120) PENCE

----------

HSBC CUTS REDROW PRICE TARGET TO 770 (790) PENCE - 'BUY'

----------

HSBC CUTS BOVIS HOMES PRICE TARGET TO 1300 (1350) PENCE - 'BUY'

----------

HSBC CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 533 (1032) PENCE - 'HOLD'

----------

HSBC RAISES MCCARTHY & STONE TO 'BUY' ('HOLD') - TARGET 160 (150) PENCE

----------

HSBC RAISES CREST NICHOLSON PRICE TARGET TO 540 (510) PENCE - 'BUY'

----------

HSBC RAISES BELLWAY PRICE TARGET TO 4290 (4250) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('EQUAL-WEIGHT')

----------

JEFFERIES RAISES PLAYTECH PRICE TARGET TO 620 (570) PENCE - 'BUY'

----------

JEFFERIES RAISES INTERMEDIATE CAPITAL PRICE TARGET TO 1600 (1570) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

RBC INITIATES SPIRE HEALTHCARE WITH 'OUTPERFORM' - TARGET 149 PENCE

----------

RBC CUTS ABCAM PRICE TARGET TO 1300 (1410) PENCE - 'SECTOR PERFORM'

----------

More News
11 Nov 2015 14:32

Abcam agrees AxioMx takeover

(ShareCast News) - Protein research tools producer Abcam has reached an agreement to acquire monoclonal antibodies producer AxioMx in a deal worth up to $45m (£29.7m). The London-listed company said it will pay $20m upfront for AxioMx, with a further $25m due based on the US-based company achieve ce

Read more
11 Nov 2015 08:56

Abcam Strikes Deal To Buy US-Based AxioMx For Up To USD45 Million

Read more
5 Nov 2015 16:31

Dividends Calendar - Week Ahead

Read more
5 Nov 2015 09:00

Abcam On Course To Meet Financial 2016 Expectations, Plans Investments

Read more
29 Oct 2015 16:13

AGM, EGM Calendar - Week Ahead

Read more
24 Sep 2015 16:20

DIRECTOR DEALINGS: ABCAM Company Secretary Smith Buys Shares

Read more
14 Sep 2015 07:21

LONDON BRIEFING: Chinese Industrial Production Disappoints

Read more
14 Sep 2015 06:37

ABCAM CFO To Step Down As It Says New Year Has Started Well

Read more
9 Sep 2015 06:54

Horizon Discovery Enters Licence, Supply Agreement With Abcam

Read more
8 Sep 2015 05:12

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Sep 2015 15:04

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Jul 2015 13:41

Abcam "back on track" with strong full-year revenues

(ShareCast News) - Antibodies and protein research products producer Abcam said it has been attracting and retaining consumers to its business and delivering market revenue growth. The group added the year ended 30 June 2015, was a successful one driven by its strategy, with revenues expected to ris

Read more
23 Jul 2015 09:29

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

Read more
23 Jul 2015 07:09

Abcam Expects To Post 12% Revenue Growth For Full Year

Read more
2 Jul 2015 08:44

BROKER RATINGS SUMMARY: Berenberg Raises AstraZeneca To Buy from Hold

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.